Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Giusi Barra
Regorafenib in Combination With Silybin as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer
Oncotarget
Oncology
Chitinase 3-Like-1 Is Produced by Human Th17 Cells and Correlates With the Level of Inflammation in Juvenile Idiopathic Arthritis Patients
Clinical and Molecular Allergy
Allergy
Immunology
Molecular Biology
Related publications
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients
Scientific Reports
Multidisciplinary
Regorafenib Adjusted Dose for Chilean Patients With Chemoresistant Metastatic Colorectal Cancer: A Case Series
ecancermedicalscience
Cancer Research
Oncology
KDR Gene as a Predictive Biomarker of Response to Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC)
Journal of Pharmacogenomics & Pharmacoproteomics
A Systematic Review and Meta-Analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer
Anticancer Research
Medicine
Cancer Research
Oncology
Regorafenib Okayed for Colorectal Cancer
Cancer Discovery
Oncology
Response to Regorafenib at an Initial Dose of 120 Mg as Salvage Therapy for Metastatic Colorectal Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Safety and Efficacy of Regorafenib in Patients With Treatment-Refractory Metastatic Colorectal Cancer in Turkey: The Single-Arm, Open-Label REGARD Study
BMJ Open
Medicine
Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib
Oncologist
Cancer Research
Medicine
Oncology
